Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells
- PMID: 20560983
- PMCID: PMC2909406
- DOI: 10.1111/j.1365-2249.2010.04119.x
Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells
Abstract
Currently the only treatment for coeliac disease is a lifelong gluten-free diet excluding food products containing wheat, rye and barley. There is, however, only scarce evidence as to harmful effects of rye in coeliac disease. To confirm the assumption that rye should be excluded from the coeliac patient's diet, we now sought to establish whether rye secalin activates toxic reactions in vitro in intestinal epithelial cell models as extensively as wheat gliadin. Further, we investigated the efficacy of germinating cereal enzymes from oat, wheat and barley to hydrolyse secalin into short fragments and whether secalin-induced harmful effects can be reduced by such pretreatment. In the current study, secalin elicited toxic reactions in intestinal Caco-2 epithelial cells similarly to gliadin: it induced epithelial cell layer permeability, tight junctional protein occludin and ZO-1 distortion and actin reorganization. In high-performance liquid chromatography and mass spectroscopy (HPLC-MS), germinating barley enzymes provided the most efficient degradation of secalin and gliadin peptides and was thus selected for further in vitro analysis. After germinating barley enzyme pretreatment, all toxic reactions induced by secalin were ameliorated. We conclude that germinating enzymes from barley are particularly efficient in the degradation of rye secalin. In future, these enzymes might be utilized as a novel medical treatment for coeliac disease or in food processing in order to develop high-quality coeliac-safe food products.
Figures




Similar articles
-
Coeliac disease: immunogenicity studies of barley hordein and rye secalin-derived peptides.Int J Exp Pathol. 2016 Aug;97(4):303-309. doi: 10.1111/iep.12199. Epub 2016 Sep 23. Int J Exp Pathol. 2016. PMID: 27659035 Free PMC article.
-
Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture.Clin Exp Immunol. 2008 Jun;152(3):552-8. doi: 10.1111/j.1365-2249.2008.03635.x. Epub 2008 Apr 16. Clin Exp Immunol. 2008. PMID: 18422736 Free PMC article.
-
Rye gamma-70 and gamma-35 secalins and barley gamma-3 hordein cross-react with omega-5 gliadin, a major allergen in wheat-dependent, exercise-induced anaphylaxis.Clin Exp Allergy. 2001 Mar;31(3):466-73. doi: 10.1046/j.1365-2222.2001.01023.x. Clin Exp Allergy. 2001. PMID: 11260160
-
In vivo gluten ingestion in coeliac disease.Dig Dis. 1998 Nov-Dec;16(6):337-40. doi: 10.1159/000016887. Dig Dis. 1998. PMID: 10207218 Review.
-
Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye.Proc Nutr Soc. 2005 Nov;64(4):434-50. doi: 10.1079/pns2005461. Proc Nutr Soc. 2005. PMID: 16313685 Review.
Cited by
-
Review article: coeliac disease, new approaches to therapy.Aliment Pharmacol Ther. 2012 Apr;35(7):768-81. doi: 10.1111/j.1365-2036.2012.05013.x. Epub 2012 Feb 13. Aliment Pharmacol Ther. 2012. PMID: 22324389 Free PMC article. Review.
-
Plant Proteases: From Key Enzymes in Germination to Allies for Fighting Human Gluten-Related Disorders.Front Plant Sci. 2019 May 29;10:721. doi: 10.3389/fpls.2019.00721. eCollection 2019. Front Plant Sci. 2019. PMID: 31191594 Free PMC article.
-
The gluten-free diet: testing alternative cereals tolerated by celiac patients.Nutrients. 2013 Oct 23;5(10):4250-68. doi: 10.3390/nu5104250. Nutrients. 2013. PMID: 24152755 Free PMC article. Review.
-
Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction.Amino Acids. 2021 Jul;53(7):1051-1063. doi: 10.1007/s00726-021-03006-7. Epub 2021 May 31. Amino Acids. 2021. PMID: 34059947 Free PMC article.
-
Non-dietary forms of treatment for adult celiac disease.World J Gastrointest Pharmacol Ther. 2013 Nov 6;4(4):108-12. doi: 10.4292/wjgpt.v4.i4.108. World J Gastrointest Pharmacol Ther. 2013. PMID: 24199026 Free PMC article. Review.
References
-
- Shan L, Molberg O, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science. 2002;297:2275–9. - PubMed
-
- Hausch F, Shan L, Santiago NA, Gray GM, Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol. 2002;283:G996–G1003. - PubMed
-
- Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002;2:647–55. - PubMed
-
- Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology. 2000;119:996–1006. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous